Systematic Review Examines Safety Of Protease Inhibitor-Based ART In Pregnant Women With HIV Infection

Infectious Disease Advisor (5/4, Mermelstein) reports, “Treatment with protease inhibitor (PI)-based antiretroviral therapy (ART) among women with HIV infection who were pregnant was associated with an increased risk for poor perinatal outcomes, including...